Biotest GmbH & Co KGaA
0N70
Company Profile
Business description
Biotest GmbH & Co KGaA is a specialist in haematology, clinical immunology, and intensive care medicine. The group develops, manufactures, and markets plasma proteins and biotherapeutic drugs. The group's value chain extends from pre-clinical and clinical development to world-wide marketing and distribution. It manufactures immunoglobulins, clotting factors, and albumins, which are derived from human blood plasma. The group markets its products in Europe, the Middle East, China, Australia, Africa, and the USA.
Contact
Landsteinerstrabe 5
DreieichHE63303
DEUT: +49 61038010
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
Employees
Stocks News & Analysis
stocks
Expanding store network for ASX listed retailer
Sales growth but lack of margin expansion due to competition.
stocks
SpaceX jumps 19% in debut, but hurdles lie ahead
Pre-IPO holders could start selling later this summer, and earnings will be an important test.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,128.00 | 14.60 | 0.16% |
| CAC 40 | 8,409.08 | 58.21 | 0.70% |
| DAX 40 | 24,932.58 | 297.28 | 1.21% |
| Dow JONES (US) | 51,844.40 | 642.14 | 1.25% |
| FTSE 100 | 10,435.51 | 36.21 | -0.35% |
| HKSE | 24,842.67 | 124.57 | 0.50% |
| NASDAQ | 26,541.42 | 652.58 | 2.52% |
| Nikkei 225 | 69,317.50 | 3,297.46 | 4.99% |
| NZX 50 Index | 13,360.59 | 33.28 | -0.25% |
| S&P 500 | 7,553.64 | 122.18 | 1.64% |
| S&P/ASX 200 | 8,914.00 | 7.00 | 0.08% |
| SSE Composite Index | 4,096.47 | 64.96 | 1.61% |